Quest Diagnostics (DGX) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to -$351.0 million.
- Quest Diagnostics' Enterprise Value rose 4868.42% to -$351.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$351.0 million, marking a year-over-year increase of 4868.42%. This contributed to the annual value of -$466.0 million for FY2024, which is 2360.66% up from last year.
- Quest Diagnostics' Enterprise Value amounted to -$351.0 million in Q3 2025, which was up 4868.42% from -$238.0 million recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' Enterprise Value ranged from a high of -$49.0 million in Q2 2023 and a low of -$1.2 billion during Q1 2021
- Over the past 5 years, Quest Diagnostics' median Enterprise Value value was -$466.0 million (recorded in 2024), while the average stood at -$463.2 million.
- As far as peak fluctuations go, Quest Diagnostics' Enterprise Value surged by 9312.76% in 2023, and later tumbled by 92089.55% in 2024.
- Quest Diagnostics' Enterprise Value (Quarter) stood at -$793.0 million in 2021, then soared by 69.99% to -$238.0 million in 2022, then tumbled by 156.3% to -$610.0 million in 2023, then grew by 23.61% to -$466.0 million in 2024, then increased by 24.68% to -$351.0 million in 2025.
- Its Enterprise Value was -$351.0 million in Q3 2025, compared to -$238.0 million in Q2 2025 and -$107.0 million in Q1 2025.